Search
Peter Molloy (left) and chairman William Garner founded Race Oncology in 2016 to commercialise Bisantrene. Photo: Attila Csaszar

Race challenges big pharma mindset

Perth-based Race Oncology has achieved early success in its strategy of commercialising drugs overlooked by big pharmaceutical companies.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Transactions

08/02/19
$0 Other
08/02/19
$0 Other
08/02/19
$0 Other
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer